Cancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing.

Prisca Olabisi Adejumo Toyin I G Aniagwu Olutosin Alaba Awolude Babatunde AdedokunMakayla KochheiserAnthonia SowunmiAbiodun PopoolaOladosu OjengbedeDezheng Huo Olufunmilayo I Olopade

Published in: JCO global oncology (2023)

Learning clinically relevant details toward cancer prevention informs health-related decisions in patients and relatives, a motivator for willingness to pay for genetic testing in low- and middle-income countries. Increased awareness may influence outcomes of cancer risk management.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
chronic kidney disease
newly diagnosed
healthcare
ejection fraction
health insurance
primary care
genome wide
squamous cell carcinoma
lymph node metastasis
dna repair
patient reported outcomes
dna damage
young adults
copy number
weight loss
skeletal muscle